Clinicians knew Victor Tinley had cancer four months before he was told about it, an inquest hears.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood Cancer United® (formerly The Leukemia & Lymphoma Society), the largest global ...

The U.S. Food and Drug Administration (FDA) on Friday approved a label expansion for Bristol Myers Squibb’s (BMY) antitumor therapy Opdivo to treat a blood cancer known as Hodgkin lymphoma as part of ...

It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...

In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and ...

Blood cancer treatment is entering a new era, bringing powerful breakthroughs that offer renewed hope to people living with leukemia, lymphoma, myeloma, and other blood cancers. Cutting-edge targeted ...

What Is Marginal Zone Lymphoma? Marginal zone lymphoma (MZL) isn’t one disease, but a group of rare, slow-growing blood cancers. They’re known as non-Hodgkin lymphomas because they start in your ...

Remission indicates symptom disappearance, not a cure, especially in chronic diseases like follicular lymphoma. Blood cancers are challenging to eradicate due to their systemic nature, requiring ...

I don’t have children of my own, so it’s hard to imagine how a parent responds to those words. But 28 years ago, my parents found themselves facing that dilemma. It’s strange to look back on a moment ...

SAN ANTONIO – Thanks to efforts from doctors, researchers, health care providers and nonprofits such as Blood Cancer United, certain types of blood cancers are no longer the terminal diagnoses that ...

ALTON - Alton’s North Elementary School has raised over $5,000 for the Light the Night campaign.This three-week campaign encourages students and ...